enVVeno Medical
NVNO
17 hedge funds and large institutions have $1.02M invested in enVVeno Medical in 2026 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 23 closing their positions.
17.1% less ownership
Funds ownership: 32.43% → 15.33% (-17%)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
52% less capital invested
Capital invested by funds: $2.1M → $1.02M (-$1.08M)
53% less funds holding
Funds holding: 36 → 17 (-19)
74% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$51.5K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.93K |
| 3 |
BlackRock
New York
|
+$1.23K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$624 |
| 5 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$22 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$564K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$64K |
| 3 |
Jane Street
New York
|
-$57.4K |
| 4 |
Two Sigma Investments
New York
|
-$51.2K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$42.5K |
NVNO Hedge Fund Activity: Q1 2026 in Review
17 of the 8,203 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q1 2026, worth a combined $1.02M — down 52% from $2.1M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of NVNO and 6 opened new positions — a net loss of 17 holders — while 5 trimmed existing stakes and 3 added.
The largest buyer was Geode Capital Management, adding an estimated $51.5K. The largest seller was Perceptive Advisors, exiting entirely with an estimated $564K sold.
- 17 institutional investors held enVVeno Medical (NVNO) as of Q1 2026, down from 36 in Q4 2025.
- Funds reported $1.02M of enVVeno Medical stock for Q1 2026, down 52% quarter-over-quarter.
- 6 funds opened new enVVeno Medical positions in Q1 2026 and 23 closed out, a net change of -17 holders.
- The largest enVVeno Medical buyer in Q1 2026 was Geode Capital Management, an estimated $51.5K added.
- The largest enVVeno Medical seller in Q1 2026 was Perceptive Advisors, an estimated $564K sold.
Based on aggregated 13F filings for Q1 2026.